首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Unsaturated dideoxy fluoro-ketopyranosyl nucleosides as new cytostatic agents: a convenient synthesis of 2,6-dideoxy-3-fluoro-4-keto-beta-D-glucopyranosyl analogues of uracil, 5-fluorouracil, thymine, N4-benzoyl cytosine and N6-benzoyl adenine.
【24h】

Unsaturated dideoxy fluoro-ketopyranosyl nucleosides as new cytostatic agents: a convenient synthesis of 2,6-dideoxy-3-fluoro-4-keto-beta-D-glucopyranosyl analogues of uracil, 5-fluorouracil, thymine, N4-benzoyl cytosine and N6-benzoyl adenine.

机译:不饱和双脱氧氟-酮吡喃糖基核苷作为新型细胞抑制剂:尿嘧啶,5-氟尿嘧啶,胸腺嘧啶,N4-苯甲酰基胞嘧啶和N6的2,6-二脱氧-3-氟-4-酮-β-D-吡喃葡萄糖基类似物的便捷合成-苯甲酰基腺嘌呤。

获取原文
获取原文并翻译 | 示例
           

摘要

The beta-protected nucleosides of uracil (2a), 5-fluorouracil (2b), thymine (2c), N(4)-benzoyl cytosine (2d) and N(6)-benzoyl adenine (2e) were synthesized by condensation of the peracetylated 3-deoxy-3-fluoro-D-glucopyranose (1) with the corresponding silylated bases. The nucleosides were deacetylated and several subsequent protection and deprotection steps afforded the partially acetylated analogues 6a-e. Selective iodination followed by hydrogenation gave the acetylated dideoxy analogues of uracil (8a), 5-fluorouracil (8b), thymine (8c), N(4)-benzoyl cytosine (8d) and N(6)-benzoyl adenine (8e), respectively. Finally, direct oxidation of the free hydroxyl group at the 4'-position of 8a-e, and simultaneous elimination reaction of the beta-acetoxyl group, afforded the desired unsaturated 2,6-dideoxy-3-fluoro-4-keto-beta-D-glucopyranosyl derivatives 9a-e. The new analogues were evaluated for antiviral and cytostatic activity. Compounds 9a-e were not active against a broad panel of DNA and RNA viruses at subtoxic concentrations. However, they were markedly cytostatic against a variety of tumor cell lines. The compounds should be regarded as potential new lead compounds to be further investigated for anticancer therapy.
机译:尿嘧啶(2a),5-氟尿嘧啶(2b),胸腺嘧啶(2c),N(4)-苯甲酰基胞嘧啶(2d)和N(6)-苯甲酰基腺嘌呤(2e)的β-保护核苷通过缩合反应合成过乙酰化的3-脱氧-3-氟-D-吡喃葡萄糖(1)和相应的甲硅烷基化碱基。核苷被脱乙酰基,随后的几个保护和脱保护步骤得到部分乙酰化的类似物6a-e。选择性碘化然后氢化得到尿嘧啶(8a),5-氟尿嘧啶(8b),胸腺嘧啶(8c),N(4)-苯甲酰基胞嘧啶(8d)和N(6)-苯甲酰基腺嘌呤(8e)的乙酰化双脱氧类似物,分别。最后,在8a-e的4'-位上直接氧化游离羟基,同时消除β-乙酰氧基的反应,得到所需的不饱和2,6-二脱氧-3-氟-4-酮-β -D-吡喃葡萄糖基衍生物9a-e。评价了新的类似物的抗病毒和细胞抑制活性。化合物9a-e在亚毒性浓度下对广泛的DNA和RNA病毒没有活性。然而,它们对多种肿瘤细胞系具有明显的细胞抑制作用。该化合物应被视为潜在的新的先导化合物,需要进一步研究以用于抗癌治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号